A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).

Mikkael A. Sekeres, Kristen Sullivan, David W. Donley et al.|Blood|2009

Cited by 15